Antonio Chistolini | Ricerc@Sapienza

Pubblicazioni

Titolo	Pubblicato in	Anno
Increased von Willebrand Factor Platelet-Binding Capacity Is Related to Poor Prognosis in COVID-19 Patients	THROMBOSIS AND HAEMOSTASIS	2023
Vaccine-induced immune thrombotic thrombocytopenia: a possible pathogenetic role of ChAdOx1 nCoV-19 vaccine encoded soluble SARS-CoV-2 spike protein	HAEMATOLOGICA	2022
Secondary prophylaxis of venous thromboembolism with direct oral anticoagulants: comparison between patients with major congenital thrombophilia versus non-thrombophilic patients	INTERNAL AND EMERGENCY MEDICINE	2022
Low in-hospital mortality rate in patients with COVID-19 receiving thromboprophylaxis: data from the multicentre observational START-COVID Register	INTERNAL AND EMERGENCY MEDICINE	2022
Thromboembolic events following mRNA vaccines for COVID 19: a case series	JOURNAL OF THROMBOSIS AND THROMBOLYSIS	2022
Immune thrombocytopenia during covid-19 pandemic: An italian monocentric experience	EJHAEM	2022
Cancer-associated venous thromboembolism: the Onco-VTE START2 - Registry	213S2 (2022) S11–S42	2022
Diagnostica di laboratorio e strumentale	Ematologia Smart, Edizioni Idelson Gnocchi 1908	2022
Complicanze in corso di emopatie ed emergenze emorragiche e trombotiche	Ematologia Smart, Edizioni Idelson Gnocchi 1908	2022
Development of Systemic Autoimmune Diseases in Healthy Subjects Persistently Positive for Antiphospholipid Antibodies: Long-Term Follow-Up Study	BIOMOLECULES	2022
SARS-CoV-2 infection predicts larger infarct volume in patients with acute ischemic stroke	FRONTIERS IN CARDIOVASCULAR MEDICINE	2022
Direct oral anticoagulants for the treatment of atrial fibrillation in patients with hematologic malignancies	JOURNAL OF THROMBOSIS AND THROMBOLYSIS	2022
"Low dose apixaban as secondary prophylaxis of venous thromboembolism in cancer patients-30 months follow-up": Comment from Serrao et al	JOURNAL OF THROMBOSIS AND HAEMOSTASIS	2022
Von Willebrand factor with increased binding capacity is associated with reduced platelet aggregation but enhanced agglutination in COVID-19 patients: another COVID-19 paradox?	JOURNAL OF THROMBOSIS AND THROMBOLYSIS	2021
Venous thromboembolism prophylaxis in patients with multiple myeloma: where are we and where are we going?	JOURNAL OF THROMBOSIS AND THROMBOLYSIS	2021
Von Willebrand factor with increased binding capacity is associated with reduced platelet aggregation but enhanced agglutination in COVID-19 patients: another COVID-19 paradox?	JOURNAL OF THROMBOSIS AND THROMBOLYSIS	2021
Malignant cerebral infarction after ChAdOx1 nCov-19 vaccination: a catastrophic variant of vaccine-induced immune thrombotic thrombocytopenia	NATURE COMMUNICATIONS	2021
Venous thromboembolism prophylaxis in plastic surgery: state of the art and our approach	EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES	2021
Single centre experience on Acquired Haemophilia A patients: Diagnosis, clinical management and analysis of factors predictive of response and outcome	HAEMOPHILIA	2021
Clinical course, management, and platelet activity assessment of splanchnic VITT: A case report	THROMBOSIS RESEARCH	2021